Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristiano Ferrario

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Discovery|April 25, 2014
Advances in the approach to novel drug clinical development for breast cancerCristiano Ferrario, Gerald Batist
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Docetaxel plus cyclophosphamide in adjuvant breast cancerCristiano Ferrario, Lawrence C Panasci
BMC Medical Genomics|January 29, 2011
The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genomeEwa Przybytkowski, Cristiano Ferrario, Mark Basik
Current Opinion in Biotechnology|December 7, 2007
Tissue microarrays: emerging standard for biomarker validationSaima Hassan, Cristiano Ferrario, Aline Mamo, et al.
BMJ Case Reports|June 14, 2014
Aromatase inhibition in relapsing low malignant potential serous tumours of the ovaryKhashayar Esfahani, Cristiano Ferrario, Philippe Le, et al.
Omics : a Journal of Integrative Biology|October 31, 2006
Microarrays as validation strategies in clinical samples: tissue and protein microarraysAdriana Aguilar-Mahecha, Saima Hassan, Cristiano Ferrario, et al.
Nuclear Medicine and Molecular Imaging|July 18, 2022
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate CancerStephan Probst, Anders Bjartell, Aseem Anand, et al.
Nuclear Medicine and Molecular Imaging|October 31, 2022
Outcomes and Factors Associated with Completion of Radium-223 TherapyRichard F Liu, Lamin Juwara, Cristiano Ferrario, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian PerspectiveCristiano Ferrario, Anna Christofides, Anil Abraham Joy, et al.
British Journal of Haematology|December 9, 2008
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitroLilian Amrein, Tiffany A Hernandez, Cristiano Ferrario, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Discovery|April 25, 2014
Advances in the approach to novel drug clinical development for breast cancerCristiano Ferrario, Gerald Batist
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Docetaxel plus cyclophosphamide in adjuvant breast cancerCristiano Ferrario, Lawrence C Panasci
BMC Medical Genomics|January 29, 2011
The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genomeEwa Przybytkowski, Cristiano Ferrario, Mark Basik
Current Opinion in Biotechnology|December 7, 2007
Tissue microarrays: emerging standard for biomarker validationSaima Hassan, Cristiano Ferrario, Aline Mamo, et al.
BMJ Case Reports|June 14, 2014
Aromatase inhibition in relapsing low malignant potential serous tumours of the ovaryKhashayar Esfahani, Cristiano Ferrario, Philippe Le, et al.
Omics : a Journal of Integrative Biology|October 31, 2006
Microarrays as validation strategies in clinical samples: tissue and protein microarraysAdriana Aguilar-Mahecha, Saima Hassan, Cristiano Ferrario, et al.
Nuclear Medicine and Molecular Imaging|July 18, 2022
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate CancerStephan Probst, Anders Bjartell, Aseem Anand, et al.
Nuclear Medicine and Molecular Imaging|October 31, 2022
Outcomes and Factors Associated with Completion of Radium-223 TherapyRichard F Liu, Lamin Juwara, Cristiano Ferrario, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian PerspectiveCristiano Ferrario, Anna Christofides, Anil Abraham Joy, et al.
British Journal of Haematology|December 9, 2008
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitroLilian Amrein, Tiffany A Hernandez, Cristiano Ferrario, et al.
Pageof 6